Published on 26 Feb 2024 on GuruFocus.com via Yahoo Finance

Surgery Partners Inc (SGRY) Reports Solid Revenue and EBITDA Growth in Full Year 2023 Results

Annual Revenue Growth: Revenue increased by 8.0% to $2.74 billion in 2023.Quarterly Revenue Growth: Fourth quarter revenue rose by 4.0% to $735.4 million.Adjusted EBITDA Growth: Full-year Adjusted EBITDA grew by 15.2% to $438.1 million.Net Loss: Net loss attributable to common stockholders was $11.9 million for the full year and $1.0 million for the fourth quarter.2024 Outlook: Revenue for 2024 is projected to be greater than $3.0 billion with Adjusted EBITDA expected to exceed $495 million.

Warning! GuruFocus has detected 5 Warning Signs with SGRY.

Surgery Partners Inc (NASDAQ:SGRY) released its 8-K filing on February 26, 2024, announcing its financial results for the fourth quarter and full year ended December 31, 2023. The company, a leading operator of short-stay surgical facilities, reported an 8.0% increase in annual revenue to $2.74 billion and a 4.0% increase in fourth-quarter revenue to $735.4 million compared to the same periods in 2022.